Our latest news, updates, announcements and media resources

VSY Biotechnology Launches Enova Hydrophobic IOLs Featuring Patented Rotaryjet™ Technology

VSY Biotechnology GmbH has officially launched its latest innovation in cataract surgery: the Enova Hydrophobic Intraocular Lenses (IOLs), enhanced with the company's patented Rotaryjet™ Preloaded Delivery System.

VSY Biotechnology’s Enova® Premium IOLs Set New Standard with 100% Glistening Free Technology

VSY Biotechnology GmbH’s groundbreaking Enova® intraocular lens is reshaping expectations in the ophthalmic industry.

VSY Biotechnology Enters the Japanese Market!

Sinusoidal Trifocal Technology® developed by VSY Biotechnology GmbH has been officially approved in Japan.

VSY Biotechnology Unveils New IOL Innovation

VSY Biotechnology GmbH, one of Germany’s leading manufacturers in the field of intraocular lenses (IOLs), has announced a major innovation set to significantly improve the quality of life for patients undergoing lens implantation.

Maestro®: The Sinusoidal IOL

VSY Biotechnology to Complete Global Rollout of its Sinusoidal Vision Technology (SVT®) at ESCRS 2024...

Strategic Partnership with Clarius Mobile Health Corp.

VSY Biotechnology GmbH, a renowned player in the biotechnology and medical device sector, and Clarius Mobile Health Corp...

Winners of the Ophthalmology Star Awards 2024 (OSA)

The winners of the Ophthalmology Star Awards 2024 (OSA) were announced at the ESCRS Congress...

10% Is Only The Beginning: VSY Biotechnology's Protectalon Dominates German Cataract Surgeries

VSY Biotechnology GmbH is proud to announce a significant achievement in the German market...

VSY Biotechnology’s In-House 100% Glistening-Free IOL Material Redefines The IOL Market

VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge 100% Glistening-Free IOL Material...

Prof. Dr. Ike Ahmed’s Experience with the “Gold...

Prof. Dr. Ike Ahmed who uses the latest technologies in the field of ophthalmology and is...

We are glad to announce VSY Biotechnology Ophth...

We are glad to announce VSY Biotechnology Ophthalmology Star Awards (OSA) 2022 at this year’s ESC...

We have been awarded...

We are proud to announce that we have been awarded certification for t...

Sinusoidal Vision Technology (SVT®) has been of...

VSY Biotechnology registered a patent with the People's Republic of China for the 'Sinusoidal Vis...

We are Glad to Announce VSY Biotechnology Ophthalm...

This year’s “Ophthalmology Star Awards” is announced at VSY Biotechnology Satellite Symposium at ESC...

VSY Biotechnology Launched AcrivaUD

The first and only trifocal presbyopia-correcting (PC-IOL) intraocular lens with patented enhance...

Discover the Golden Ratio in IOL Technology™

Join us at the upcoming ESCRS congress to discover how VSY Biotechnology reaches the Golden Ratio...

Golden Ratio in Trifocal IOL Technology™: Acriv...

VSY Biotechnology introduces the new concept of “Golden Ratio in IOL Technology™” with its unique...

VSY Biotechnology’s invention has been registered ...

VSY Biotechnology’s invention, the Rotaryjet Preloaded Injector containing an accessory system for t...

Enova® is Available Now in C Haptic Model

VSY Biotechnology announces the launch of the Enova® C Haptic Model IOL. Enova® is the first and onl...

VSY Biotechnology GmbH signs agreement with WAKAMO...

Leinfelden – Echterdingen, Germany March 19, 2021, ­ VSY Biotechnology GmbH, an innovation-driven co...